In the past decade, the emergence of chimeric antigen receptor (CAR) T-cell therapy has led
to a cellular immunotherapy revolution against various cancers. Although CAR-T cell …

Breast cancer is the leading cancer in women. Around 20–30% breast cancer patients
undergo invasion or metastasis after radical surgical resection and eventually die. Number …

Adoptive immunotherapy with virus-specific cytotoxic T cells (VSTs) has evolved over the
last three decades as a strategy to rapidly restore virus-specific immunity to prevent or treat …

T cells engineered to express HIV-specific chimeric antigen receptors (CARs) represent a
promising strategy to clear HIV-infected cells, but to date have not achieved clinical benefits …

CAR-T cell therapy has revolutionized immunotherapy but its allogeneic application, using
various strategies, faces significant challenges including graft-versus-host disease and graft …

The Quantum cell expansion system manufactured by Terumo-BCT is perhaps the most
widely reported Good Manufacturing Practice–compliant bioreactor used for the expansion …

Cancer is one of the most devastating complications of kidney transplantation and
constitutes one of the leading causes of morbidity and mortality among solid organ …

Adoptive cell therapies (ACTs) have revolutionized cancer immunotherapy, prompting
exploration into their application against oncoviruses. Oncoviruses such as human …

At present, recipients of allogeneic hematopoietic stem-cells are still suffering from recurrent
infections after transplantation. Infusion of virus-specific T cells (VST) post-transplant …

Immunotherapy is a beneficial treatment approach for multiple cancers, however, current
therapies are effective only in a small subset of patients. Adoptive cell transfer (ACT) is a …